Eriko Sugiyama
Overview
Explore the profile of Eriko Sugiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akatsuka M, Sugiyama E
Cureus
. 2024 Jan;
15(12):e50766.
PMID: 38239529
Precise placement of peripherally inserted central catheters (PICCs) is essential for avoiding treatment risks and ensuring the success of treatment. This is typically performed under imaging guidance, but imaging modalities...
2.
Harita M, Miwa T, Shiga H, Yamada K, Sugiyama E, Okabe Y, et al.
Geriatr Gerontol Int
. 2019 Apr;
19(5):384-391.
PMID: 30968523
Aim: Individuals with olfactory or gustatory impairment often have associated difficulties with food-related activities. As both functions decline in older adults, we investigated the association of these impairments with sarcopenia/frailty...
3.
Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Tanaka S, Sunaoshi T, et al.
Exp Ther Med
. 2017 Oct;
14(4):3754-3760.
PMID: 29042975
Fusion images of diffusion-weighted whole-body imaging with background body signal suppression and T2-weighted image (DWIBS/T2) demonstrate a strong signal for malignancies, with a high contrast against the surrounding tissues, and...
4.
Tomizawa M, Shinozaki F, Tanaka S, Sunaoshi T, Kano D, Sugiyama E, et al.
Exp Ther Med
. 2017 Jul;
14(1):743-747.
PMID: 28672993
In a clinical setting, it is important to diagnose complications of acute cholecystitis accurately. Diffusion-weighted whole body imaging with background body signal suppression/T2-weighted image fusion (DWIBS/T2) provides high signal intensity...
5.
Tomizawa M, Shinozaki F, Tanaka S, Sunaoshi T, Kano D, Sugiyama E, et al.
Exp Ther Med
. 2017 Jul;
14(1):730-734.
PMID: 28672991
Prompt and accurate diagnosis is critical in the treatment of acute cholecystitis. Diffusion-weighted whole-body magnetic resonance imaging with background body signal suppression/T2 image fusion (DWIBS/T2) identifies areas with high signal...
6.
Tomizawa M, Shinozaki F, Fugo K, Tanaka S, Sunaoshi T, Kano D, et al.
Exp Ther Med
. 2017 Jun;
13(6):3509-3515.
PMID: 28587434
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) images show significant contrast for cancer tissues against non-cancerous tissues. Fusion of a DWIBS and a T2-weighted image (DWIBS/T2) can be...
7.
Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Fugo K, Sunaoshi T, et al.
Exp Ther Med
. 2017 Mar;
13(2):639-644.
PMID: 28352344
Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion (DWIBS/T2) is useful for the diagnosis of cancer as it presents a clear contrast between cancerous and non-cancerous tissue. The...
8.
Tomizawa M, Shinozaki F, Fugo K, Sunaoshi T, Kano D, Tanaka S, et al.
Mol Clin Oncol
. 2016 Jun;
5(1):44-48.
PMID: 27330763
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) yields positive results for cancer against the surrounding tissues. The combination of DWIBS and T2-weighted images (DWIBS/T2) in the diagnosis of...
9.
Tomizawa M, Shinozaki F, Fugo K, Sunaoshi T, Sugiyama E, Kano D, et al.
Exp Ther Med
. 2016 May;
11(5):1777-1780.
PMID: 27168802
Differentiation between adenomyomatosis (ADM) and cancer of the gallbladder is necessary during diagnosis. Diffusion-weighted whole body imaging with background body signal suppression (DWIBS) images are able to indicate cancer and...
10.
Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Fugo K, Sunaoshi T, et al.
Abdom Imaging
. 2015 Sep;
40(8):3012-9.
PMID: 26350283
Purpose: Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion (DWIBS/T2) strongly contrasts cancerous tissue against background healthy tissues. Positron emission tomography/computed tomography (PET/CT) applies the uptake of 18-fluorodeoxyglucose...